Search results
Brain Cancer Cure Soon? New Treatment Removes Tumor In Woman Within 5 Days
Mashable India· 3 hours agoExperts from the Massachusetts General Hospital (MGH) recently conducted a study wherein they...
Revolution sets sights on Phase III trial for pan-RAS inhibitor
Pharmaceutical Technology· 17 hours agoAccording to Revolution, primary endpoint data is expected in 2026 and 2027. KRAS is a gene that...
German CDMO outlays $980m on GLP-1 manufacturing expansion
Pharmaceutical Technology· 18 hours agoThese plans, alongside previous expansions made this year, aim to help Corden achieve its $1bn 2028...
SOTIO partners with Biocytogen to expand ADC oncology pipeline
Pharmaceutical Technology· 18 hours agoOther Phase I/II candidates include BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting...
All about bone cancer: Symptoms, causes and treatment strategies
CNBC Awaaz· 21 hours agoDespite being very uncommon, bone cancer is a serious condition that can have a major effect on a person's life. The most prevalent kinds are osteosarcoma, chondrosarcoma, and Ewing's sarcoma ...
Vertex taps Orum to hunt for better ‘preconditioning’ drugs
BioPharma Dive· 22 hours agoThe deal gives Vertex rights to use Orum’s ADC-like technology to discover gentler preparatory...
Cytonics begins Phase I trial of new therapy to treat knee osteoarthritis
Clinical Trials Arena· 23 hours agoCYT-108's unique aspect is its dual approach to protease inhibition, which targets both specific and...
Study links COVID-19 to faster onset of type 1 diabetes symptoms in children - The Economic Times
The Economic Times· 23 hours agoResearchers discovered that youngsters who were both virus-infected and in the early stages of type...
Non-small cell lung cancer: the global clinical trials landscape 2024
Pharmaceutical Technology· 24 hours agoNon-small cell lung cancer accounts for around 85% of lung cancer cases worldwide. Promising...
Sumitomo Pharma’s DSP-5336 gains FDA fast track for AML
Pharmaceutical Technology· 1 day agoDSP-5336, a small molecule inhibitor, targets the menin and mixed-lineage leukaemia (MLL) protein...